TL;DR
Get kitchen staples and gadgets delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Food Safety News’ October 2026 Sunday Edition looks back at the cultivated-meat sector’s rise and a wave of company shutdowns, including Believer Meats, which closed after completing a North Carolina plant but before producing meat there. The report links the setbacks to difficulty raising capital, high biomanufacturing costs and investors’ shorter return timelines; it does not establish that the technology or sector has ended.
Food Safety News’ October 2026 Sunday Edition examines the sharp change in fortunes for cultivated-meat companies, from a period of heavy investment to a series of shutdowns in 2025. The report says firms struggled to secure funding as investors faced high manufacturing costs and longer timelines to commercial viability. It describes Believer Meats’ closure after the company completed a North Carolina factory, but before the facility produced any meat.
The article reports that the Good Food Institute put investment in cultured meat and seafood companies at more than $2.5 billion from 2021 through 2023. It cautions that the figure may be an underestimate because investment was moving quickly and could be difficult to track. By 2023, about half of venture-capital investment went to five companies named in the report: Upside Foods, Believer Meats, Wildtype, Aleph Farms and Mosa Meat. The report also identifies sovereign wealth funds, Tyson Foods and JBS among sources of investment.
The setbacks described include the late-2025 shutdowns of Dutch cultivated-pork company Meatable, UK cell-manufacturing company CellRev and Dutch fish-fat developer Upstream Foods. According to the report, CellRev could not meet commercial milestones in time to secure investment, while Upstream Foods was unable to raise the capital it needed. Meatable closed after acquiring Uncommon Bio’s cultivated-meat platform, which was intended to expand its product plans.
The report singles out Believer Meats, formerly Future Meat Technologies, for the scale of its planned operation. The company completed a $125 million, 200,000-square-foot manufacturing plant near Raleigh, North Carolina, equipped with bioreactors and centrifuges. It had government approval, according to the article, but ceased operations after losing a major financial backer and failing to obtain a last-minute loan. The facility had not produced meat before the company closed.
Funding Meets Factory Costs
The closures show the difference between attracting investment and establishing a business that can manufacture cultivated meat at a commercial scale. A completed factory and regulatory approval did not keep Believer Meats operating when its financing fell through. For workers, local communities and investors, the example illustrates the risk that large facilities and ambitious production plans may not translate into an active business.
The report attributes the wider funding chill partly to a mismatch in timelines: venture funds often seek substantial returns within five to seven years, while the article says cultivated meat may be at least a decade from market viability. It also points to costly bioreactors, energy use and specialized nutrient solutions. Those are explanations presented by the report, not proof that every company faces the same costs or prospects.
For consumers, the closures matter because they affect how soon cultivated products might reach the market and in what quantities. The report documents company setbacks, not the end of cultivated meat research or a definitive verdict on the technology. Its account makes clear that commercial progress depends on more than developing a product: firms also need sustained funding and a workable route to production.
As an affiliate, we earn on qualifying purchases.
From Cell Samples to Scale
Cultivated meat is made by growing animal cells rather than raising an animal for slaughter. The Sunday Edition describes the general approach as taking a small sample of animal cells, placing them in a growth medium with nutrients, and growing them in a bioreactor. The intended result is a product resembling conventional meat. That description explains the technology’s aim; it does not establish that every company uses the same process or has achieved commercial production.
The idea predates the recent startup boom. The article recalls a 1931 essay by Winston Churchill, who imagined growing meat parts separately rather than raising a whole chicken. Decades later, investment accelerated: the report says cultivated-meat companies drew more than $2.5 billion between 2021 and 2023, with established meat businesses and government-linked funds among the backers.
The report’s focus is the reversal that followed, especially the 2025 closures. Believer Meats had been positioned as a major manufacturing project near Raleigh and was described as a source of local pride. Its shutdown shortly after losing financial support made the gap between construction and sustained production particularly visible.
“Cultured meat and seafood companies attracted over $2.5 billion in investment from 2021 through 2023.”
— Food Safety News, citing the Good Food Institute
Commercial Prospects Remain Open
The report does not establish when cultivated meat will reach commercial viability, how many firms remain able to operate, or whether the companies that closed will be replaced by new entrants. Its estimate that market viability may be at least a decade away is presented as a broad expectation, not a fixed timetable. It also does not provide a cost comparison across companies or explain how production costs might change with scale.
Believer Meats’ closure is described as following the loss of a major financial backer and the failure to secure a last-ditch loan. The source does not name that backer or provide further details about the financing negotiations. Nor does it give a fuller account of the status of the completed plant after the company stopped operating. The report records shutdowns and financial obstacles; it does not say that cultivated meat production is impossible or that all firms have ceased work.
Signs to Watch in Production
The Sunday Edition does not announce a new launch, funding round or regulatory decision for the cultivated-meat companies it discusses. The next developments to watch are whether surviving firms can raise enough capital to meet production milestones, whether manufacturing costs fall, and whether companies demonstrate steady output beyond pilot or demonstration settings.
Any claim of commercial progress will need to be judged against concrete details: production volumes, operating facilities, funding, regulatory status and whether products are actually being sold. The report supplies no dates for such milestones. For now, its clearest account is of the sector’s recent shift from investment enthusiasm to a difficult test of whether companies can finance and operate large-scale production.
Key Questions
What is cultivated meat?
Cultivated meat is produced by growing animal cells in a controlled environment rather than raising an animal for meat. The report describes cells being grown with nutrients in a bioreactor, with the aim of producing meat-like products.
How much investment did cultivated-meat companies attract?
The Good Food Institute reported that cultured meat and seafood companies received more than $2.5 billion from 2021 through 2023. Food Safety News says the total may be an underestimate; the report does not give a different verified figure.
Why did some cultivated-meat companies close?
The report gives company-specific reasons, including difficulty securing investment and meeting commercial milestones. It also points to expensive biomanufacturing inputs and a mismatch between venture investors’ typical return timelines and the longer path to commercial viability.
Did Believer Meats produce cultivated chicken at its North Carolina plant?
According to the report, Believer Meats ceased operations before producing any meat at its completed 200,000-square-foot facility near Raleigh.
Does the report say cultivated meat is no longer being developed?
No. It recounts several shutdowns and describes financing and production challenges, but it does not say that every cultivated-meat company has closed or that development has ended.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
